These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36928879)

  • 1. [Venous thromboembolism and antiphospholipid syndrome - considerations on diagnosis and treatment].
    van Mens TE; Middeldorp S; Coppens M
    Ned Tijdschr Geneeskd; 2023 Mar; 167():. PubMed ID: 36928879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid Syndrome in Patients with Venous Thromboembolism.
    Pengo V; Denas G
    Semin Thromb Hemost; 2023 Nov; 49(8):833-839. PubMed ID: 35728601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic antiphospholipid syndrome: From guidelines to clinical management.
    Paredes-Ruiz D; Martin-Iglesias D; Ruiz-Irastorza G
    Med Clin (Barc); 2024 Aug; 163 Suppl 1():S22-S30. PubMed ID: 39174150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilemmas in the diagnosis and management of antiphospholipid syndrome.
    Manning JE; Arachchillage DJ
    J Thromb Haemost; 2024 Aug; 22(8):2156-2170. PubMed ID: 38705387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome.
    Arachchillage DR; Efthymiou M; Mackie IJ; Lawrie AS; Machin SJ; Cohen H
    J Thromb Haemost; 2014 Nov; 12(11):1801-9. PubMed ID: 25196808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic manifestations of the antiphospholipid syndrome: integrating molecular and clinical lessons.
    Muscal E; Brey RL
    Curr Rheumatol Rep; 2008 Jan; 10(1):67-73. PubMed ID: 18457615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
    Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
    Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Antiphospholipid Syndrome.
    Arachchillage DRJ; Pericleous C
    Semin Thromb Hemost; 2023 Apr; 49(3):295-304. PubMed ID: 36646109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Zuily S; Cohen H; Isenberg D; Woller SC; Crowther M; Dufrost V; Wahl D; Doré CJ; Cuker A; Carrier M; Pengo V; Devreese KMJ
    J Thromb Haemost; 2020 Sep; 18(9):2126-2137. PubMed ID: 32881337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance and treatment of antiphospholipid antibodies].
    Godeau B; Piette JC
    Presse Med; 2004 Aug; 33(14 Pt 1):944-52. PubMed ID: 15509054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
    Pengo V; Denas G
    Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
    Wu X; Cao S; Yu B; He T
    Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.